These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 22040410)
1. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells. Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410 [TBL] [Abstract][Full Text] [Related]
2. Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity. Zhang B; Sun J; Yu SP; Chen C; Liu B; Liu ZF; Ren BC; Ming HL; Yang XJ Chin Med J (Engl); 2012 Dec; 125(24):4344-8. PubMed ID: 23253699 [TBL] [Abstract][Full Text] [Related]
3. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells. Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436 [TBL] [Abstract][Full Text] [Related]
4. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372 [TBL] [Abstract][Full Text] [Related]
5. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice]. Song WC; Fei XF; Dong J Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405 [TBL] [Abstract][Full Text] [Related]
6. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970 [TBL] [Abstract][Full Text] [Related]
7. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions. Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679 [TBL] [Abstract][Full Text] [Related]
8. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas. He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436 [TBL] [Abstract][Full Text] [Related]
9. Characterization of glioma stem-like cells from human glioblastomas. Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568 [TBL] [Abstract][Full Text] [Related]
10. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma]. Bi CL; Fang JS; Chen FH; Wang YJ; Wu J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043 [TBL] [Abstract][Full Text] [Related]
11. The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells. Yang B; Wang Y; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C Ultrastruct Pathol; 2012 Dec; 36(6):404-8. PubMed ID: 23216238 [TBL] [Abstract][Full Text] [Related]
14. [Correlative study of distribution of brain tumor stem cell with micro-vascular system]. Li MW; Niu CS Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050 [TBL] [Abstract][Full Text] [Related]
15. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro. Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940 [TBL] [Abstract][Full Text] [Related]
16. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells. Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD133 promotes drug resistance in C6 glioma cells. Angelastro JM; Lamé MW Mol Cancer Res; 2010 Aug; 8(8):1105-15. PubMed ID: 20663862 [TBL] [Abstract][Full Text] [Related]
18. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells. Lehnus KS; Donovan LK; Huang X; Zhao N; Warr TJ; Pilkington GJ; An Q Int J Oncol; 2013 Mar; 42(3):1011-7. PubMed ID: 23340741 [TBL] [Abstract][Full Text] [Related]
19. Correlation between glioblastoma stem-like cells and tumor vascularization. He H; Niu CS; Li MW Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709 [TBL] [Abstract][Full Text] [Related]